Indapamide Mylan Generics Italia (Indapamide)

Indapamide blocks the reabsorption of sodium and chloride ions in the distal convoluted tubule of the kidney. This inhibition leads to increased urine output, reduced plasma volume, and decreased peripheral vascular resistance, collectively resulting in lower arterial blood pressure.

The appropriate dose of indapamide is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Patients should follow the dosage instructions provided by their healthcare professional and not adjust the dose on their own.

Safety data for indapamide in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class, which primarily reduces blood pressure by promoting diuresis. Compared with ACE inhibitors or calcium‑channel blockers, it may be less effective as monotherapy for severe hypertension but is often combined with those agents to achieve better control and to counteract fluid retention.

Indapamide tablets should be stored at ambient temperature, below 25 °C, in the original container. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency throughout its shelf life.

Indapamide is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional. Dosing time (morning or evening) is determined by the prescriber based on therapeutic goals.

Serious adverse events, though uncommon, include severe dehydration, significant electrolyte imbalances such as hyponatremia, and hypersensitivity reactions that can manifest as rash or anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like faintness, rapid weight loss, or severe allergic signs.

Indapamide is contraindicated in patients with known hypersensitivity to the drug or other thiazide‑like diuretics, in those with severe renal impairment, and in individuals with anuria. Caution is also advised for patients with uncontrolled diabetes, gout, or severe liver disease, and it should be avoided in these contexts unless specifically directed by a physician.